Navigation Links
Cephalon Reports Record Earnings and Raises 2010 Guidance

p>1,252,4221,337,963   LONG-TERM DEBT

384,638363,696   DEFERRED TAX LIABILITIES, net

219,091159,328   OTHER LIABILITIES

279,049111,728Total liabilities

2,135,2001,972,715REDEEMABLE EQUITY

178,245207,307EQUITY:Cephalon Stockholders' Equity   Common stock, $0.01 par value

784780   Additional paid-in capital

2,407,5632,534,070   Treasury stock, at cost

(216,597)(208,427)   Accumulated earnings (deficit)

153,470(178,659)   Accumulated other comprehensive income

164,888114,194Total Cephalon stockholders' equity

2,510,1082,261,958Noncontrolling Interest

62,839216,115Total equity


210,919Adjustments to reconcile net income to net cash provided by operating activities:Deferred income tax expense (benefit)

(27,976)(40,182)Depreciation and amortization

163,049136,403Stock-based compensation expense

31,74036,710Amortization of debt discount and debt issuance costs

51,31841,273Loss (gain) on foreign exchange contracts

9,499(26,754)Gain on acquisition of Arana

-(10,008)IPR&D from Acusphere deconsolidation


1,749(5,079)Changes in operating assets and liabilities:Receivables


31,967(7,060)Other assets

7,48032,206Accounts payable, accrued expenses and deferred revenues

53,39589,192Other liabilities

5,047(43,059)Net cash provided by operating activities

650,540517,131CASH FLOWS FROM INVESTING ACTIVITIES:Purchases of property and equipment

(34,989)(43,647)Proceeds from sale of property and equipment

4,748-Cash balance from consolidation of variable interest entity<

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
3. Cephalon Completes Acquisition of Arana Therapeutics
4. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Cephalons New Product Launches Pace Record 2008 Sales
9. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
10. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
(Date:8/1/2014)... Chantel Lee ’15 and Eli Capello ’15 sacrificed a ... Dr. Juan Rodriguez, Professor of Physics, in an effort to ... disease caused by changes in the blood vessels of the ... quite remarkable,” said Rodriguez. “They took on a graduate level ... together carried it to near completion in just a few ...
(Date:8/1/2014)... CHICAGO , Aug. 1. 2014 As ... U.S., the 2014 AACC Annual Meeting & Clinical Lab ... testing and patient care are introduced to the healthcare ... by the Expo,s 650 exhibitors will include the latest ... Advances in smartphones and biosensors have enabled ...
(Date:8/1/2014)... 2014 Research and Markets has ... Polymorphism (SNP) Genotyping and Analysis Market 2014-2018" report ... Single Nucleotide Polymorphism (SNP) genotyping is ... in the genome of various species. SNPs are commonly ... analysis technology can analyze thousands of SNPs and has ...
(Date:8/1/2014)... 01, 2014 Testing the mechanical ... a better understanding embryonic development. How and ... structurally and functionally distinct tissues is important because ... Prof. Todd McDevitt, Melissa Kinney, and Rabbia Saeed ... with biochemical cues to control many aspects of ...
Breaking Biology Technology:Two Centenary College Students Tackle Diabetic Retinopathy Research 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 3Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Study Links Biomechanics and Gene Expression in Stem Cells 2
... an online application provider, have won the 2006 "Creating ... Claire Area Economic Development Corp . , ,Winners in ... LLC, an online application service provider of real estate ... of multi-oil combustion systems. , ,In addition to recognition, ...
... - In a move designed to give Wisconsin a ... announced a partnership agreement with the Wisconsin Alumni ... cell research at non-profit and academic institutions in Wisconsin ... patents held by WARF. , ,In what the administration ...
... esoteric territory, but a Madison court is taking some of ... might be giving smaller drug companies a chance to defend ... example occurred last month. After a relatively speedy trial that ... District Court for the Western District of Wisconsin first ...
Cached Biology Technology:Eau Claire business contest honors tech start ups 2Doyle, WARF announce partnership to lure stem cell companies 2Doyle, WARF announce partnership to lure stem cell companies 3With patents, Wisconsin court gaining reputation as a "rocket docket" 2With patents, Wisconsin court gaining reputation as a "rocket docket" 3With patents, Wisconsin court gaining reputation as a "rocket docket" 4
(Date:8/1/2014)... the fossil record about 200,000 years ago, but it ... and advanced tools became widespread. , A new ... Anthropology finds that human skulls changed in ways ... the same time that culture was blossoming. , "The ... rapid cultural exchange probably came at the same time ...
(Date:8/1/2014)... research will provide enormous opportunities for both biological ... replicate any other cells in the body, offering ... spinal cords, treating kidney, liver and lung diseases ... profit is staggering. Prof. Jinhui Chen from Indiana ... research still faces myriad biological, ethical, legal, political, ...
(Date:8/1/2014)... soon have a more effective way to control the ... from the National University of Singapore (NUS). , The ... Department of Pharmacology at the NUS Yong Loo Lin ... a recent PhD graduate from the Saw Swee Hock ... a common herbal-based anti-malarial drug, can be used to ...
Breaking Biology News(10 mins):Society bloomed with gentler personalities and more feminine faces 2NUS study shows effectiveness of common anti-malarial drug in controlling asthma 2
... The Center for Alternatives to Animal Testing (CAAT) at ... the National Academy of Sciences (NAS) and the authors of ... Vision and a Strategy, to receive the CAAT Recognition Award ... the 7th World Congress on Alternatives and Animal Use in ...
... thing that comes to mind when people think of Alzheimer,s ... Korea and France, this might change. That,s because these researchers ... "RanBP9" might be the key that unlocks an entirely new ... research report published online in The FASEB Journal ...
... and scientists need an informed, thoughtful, and open-minded citizenry. ... is strikingly inconsistent with the low level of scientific ... the "Year of Science," professional scientific organizations and grassroots, ... focus on the importance of science now and in ...
Cached Biology News:Scientists begin to untangle root cause of Alzheimer's disease 2How to advance scientific literacy 2How to advance scientific literacy 3
Recombinant Mouse Noggin...
Mouse Iduronate 2-Sulfatase Affinity Purified Polyclonal Ab Keywords: Sulfatases, Iduronate 2-Sulfatase, Mucopolysaccharidosis, Hunter Syndrome, Glycobiology Protein Family: Proteoglycan Regu...
Immunogen: Synthetic Peptide: C N(185) D G T E F G G S I Y Q K(197) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: